Sheitman B B, Lee H, Strous R, Lieberman J A
Dorothea Dix Hospital, Raleigh, NC 27603, USA.
Schizophr Bull. 1997;23(4):653-61. doi: 10.1093/schbul/23.4.653.
A first episode of psychosis is a traumatic experience for patients and families. At the time of initial evaluation, the differential diagnosis should include a broad range of neurological, general medical, and psychiatric conditions. Methodological advances in operationally defining illness onset, "offset," and remission have allowed more careful studies of treatment response in first-episode patients. These studies strongly support the efficacy of antipsychotic medication as both acute and maintenance treatment for patients with a first episode of psychosis. The optimal duration of maintenance treatment, however, has not been determined, and patients at low risk for relapse following medication withdrawal cannot be identified with specificity. First-episode psychotic patients typically experience 12 to 24 months of psychosis before receiving treatment, and a long duration of untreated psychosis may be associated with a poorer treatment response. Early intervention may improve outcome in first-episode psychosis, and the use of novel antipsychotics with improved efficacy and fewer side effects may improve medication compliance and reduce morbidity associated with repeated relapses.
首次发作的精神病对患者及其家人来说是一次创伤性经历。在初次评估时,鉴别诊断应包括广泛的神经、普通医学和精神疾病。在操作性定义疾病发作、“缓解”和缓解方面的方法学进展,使得对首发患者的治疗反应能够进行更细致的研究。这些研究有力地支持了抗精神病药物作为首次发作精神病患者急性和维持治疗的有效性。然而,维持治疗的最佳持续时间尚未确定,且无法特异性地识别出停药后复发风险较低的患者。首发精神病患者在接受治疗前通常会经历12至24个月的精神病发作,而长时间未治疗的精神病可能与较差的治疗反应相关。早期干预可能改善首发精神病的预后,使用疗效更佳且副作用更少的新型抗精神病药物可能会提高药物依从性,并降低与反复复发相关的发病率。